Method and apparatus for delivering a substance to an individual

1. A method comprising:

delivering, by a microfluidic system of a sensing device coupled to a body part of an individual at a first time, a first dosage of a substance, wherein the substance comprises at least one of an anti-allergy or anti-asthma compound;

receiving, by the sensing device at a second time, a first request by the individual to administer a second dosage of the substance;

determining, based at least in part on particulate data received from a particulate sensor of the sensing device at a second time, an environmental condition that contributes to an ailment that the substance is configured to treat, wherein the environmental condition includes air particulates in air surrounding the individual in the environment;

determining the second dosage of the substance based at least in part on the environmental condition;

determining, by the sensing device, that a first time period between the first time and the second time is less than a minimum amount of time required between consecutive dosage deliveries of the substance;

preventing the second dosage from being delivered by the microfluidic system based at least in part on determining that the first time period is less than the minimum amount of time required between consecutive deliveries of the substance;

determining, by the sensing device at a third time, a second environmental condition that contributes to the ailment;

determining, by the sensing device, that a second time period between the first time and the third time is greater than or equal to the minimum amount of time required between the consecutive dosage deliveries of the substance; and

responsive to determining that the second time period is greater than or equal to the minimum amount of time required between the consecutive dosage deliveries of the substance and in response to determining the second environmental condition, initiating, by the microfluidic system, delivery of the second dosage of the substance to the body part of the individual.

2. The method of claim 1 , wherein the minimum amount of time is based at least in part on an amount of the substance that will lessen an effectiveness of the substance when delivered to the individual.

3. The method of claim 1 , further comprising:

obtaining, by the sensing device, sensing data associated with a biological measurement of the individual; and

determining from the biological measurement that the second dosage has improved a biological condition of the individual adjustable by the second dosage.

4. The method of claim 3 , further comprising adapting one or more of a procedure, a treatment, or a timer associated with the biological condition based at least in part on determining that the second dosage has improved the biological condition.

5. The method of claim 1 , further comprising:

obtaining, by the sensing device, sensing data associated with a biological measurement of the individual; and

determining from the biological measurement that the second dosage has failed to improve a biological condition of the individual adjustable by the second dosage.

6. The method of claim 5 , further comprising adapting one or more of a procedure, a treatment, or a timer associated with the biological condition based at least in part on determining that the second dosage has failed to improve the biological condition.

7. A system comprising:

a microfluidic delivery device coupled to a body part of an individual;

a sensing device;

one or more processors; and

one or more non-transitory computer-readable media storing instructions that, when executed by the one or more processors, cause the one or more processors to perform operations comprising:

causing the microfluidic delivery device to deliver a first dosage of a substance at a first time, wherein the substance comprises at least one of an anti-allergy or anti-asthma compound;

receiving, from the sensing device at a second time, a first request by the individual to administer a second dosage of the substance;

determining, at a second time and based at least in part on particulate data received from the sensing device, an environmental condition that contributes to an ailment that the substance is configured to treat, wherein the environmental condition includes air particles in air surrounding the individual in the environment;

determining the second dosage of the substance based at least in part on the environmental condition;

determining that a first time period between the first time and the second time is less than a minimum amount of time required between consecutive dosage deliveries of the substance;

preventing the second dosage from being delivered by the microfluidic delivery device based at least in part on determining that the first time period is less than the minimum amount of time required between consecutive deliveries of the substance;

determining, at a third time, a second environmental condition associated with the ailment;

determining that a second time period between the first time and the third time is greater than or equal to the minimum amount of time required between the consecutive dosage deliveries of the substance; and

responsive to determining that the second time period is greater than or equal to the minimum amount of time required between the consecutive dosage deliveries of the substance and in response to determining the second environmental condition, causing the microfluidic delivery device to deliver the second dosage of the substance to the body part of the individual.

8. The system of claim 7 , wherein the microfluidic delivery device comprises one or more micro-needles, one or more reservoirs configured to store the substance, and a piezo pump coupled to the one or more reservoirs and configured to deliver, in response to an instruction received from the one or more processors, the substance via the one or more micro-needles from the one or more reservoirs.

9. The system of claim 7 , the operations further comprising:

determining a dosage policy based on the environmental condition,

wherein the minimum amount of time, a first amount associated with the first dosage, or a second amount associated with the second dosage are based at least in part on the dosage policy.

10. The system of claim 7 , wherein the minimum amount of time is based at least in part on an amount of the substance that will cause an overdose of the substance when delivered to the individual.

11. One or more non-transitory computer-readable media storing instructions that, when executed by one or more processors, cause the one or more processors to perform operations comprising:

delivering, by a microfluidic system of a sensing device coupled to a body part of an individual at a first time, a first dosage of a substance, wherein the substance comprises at least one of an anti-allergy or anti-asthma compound;

receiving, by the sensing device at a second time, a first request by the individual to administer a second dosage of the substance;

determining, based at least in part on particulate data received from a particulate sensor at the second time, an environmental condition that contributes to an ailment that the substance is configured to treat, wherein the environmental condition includes air particulates in air surrounding the individual in the environment;

determining the second dosage of the substance based at least in part on the environmental condition;

determining, by the sensing device, that a first time period between the first time and the second time is less than a minimum amount of time required between consecutive dosage deliveries of the substance;

preventing the second dosage from being delivered by the microfluidic system based at least in part on determining that the first time period is less than the minimum amount of time required between consecutive deliveries of the substance;

determining, at a third time, a second environmental condition associated with the ailment;

determining, by the sensing device, that a second time period between the first time and the third time is greater than or equal to the minimum amount of time required between the consecutive dosage deliveries of the substance; and

responsive to determining that the second time period is greater than or equal to the minimum amount of time required between the consecutive dosage deliveries of the substance and in response to determining the second environmental condition, initiating, by the microfluidic system, delivery of the second dosage of the substance to the body part of the individual.

12. The one or more non-transitory computer-readable media of claim 11 , wherein the minimum amount of time is based at least in part on an amount of the substance that will lessen an effectiveness of the substance when delivered to the individual.

13. The one or more non-transitory computer-readable media of claim 11 , wherein the microfluidic system comprises one or more micro-needles, one or more reservoirs configured to store the substance, and a piezo pump coupled to the one or more reservoirs and configured to deliver, in response to an instruction received from the one or more processors, the substance via the one or more micro-needles from the one or more reservoirs.

14. The one or more non-transitory computer-readable media of claim 11 , the operations further comprising:

determining a dosage policy based on the environmental condition,

wherein the minimum amount of time, a first amount associated with the first dosage, or a second amount associated with the second dosage are based at least in part on the dosage policy.

15. The one or more non-transitory computer-readable media of claim 11 , further comprising preventing the second dosage from being delivered by the microfluidic system based at least in part on determining that the first time period is associated with a decrease in effectiveness of the substance.